Stendra Enhances ED Treatment in American Men with Endocrine Disorders: Study Finds
Reading Time: 2 minutes Introduction Endocrine disorders, such as diabetes and hypogonadism, can significantly impact the quality of life for American men, particularly in the realm of sexual health. These conditions often lead to erectile dysfunction (ED), a common yet distressing issue that can strain relationships and diminish self-esteem. Stendra (avanafil), a phosphodiesterase type 5 (PDE5) inhibitor, has emerged as a potential treatment option for ED. This article explores the efficacy of Stendra in American men with endocrine disorders, based on a recent randomized, double-blind, placebo-controlled study. Study Design and Participants The study involved 250 American men aged 18-65 with a confirmed diagnosis of...


